Lorence H. Kim, Chief Financial Officer at Moderna, Inc. (MRNA), sold 38,866 shares at $26.74 ($1.0M) on 2020-03-16, disclosed to the SEC on 2020-03-18.
Open-market sale of $1.0M MRNA by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $24.68 | 2,792 | $69K | 6.8% |
| 2 | $24.68 | 2,792 | $69K | 6.8% |
| 3 | $25.85 | 6,704 | $173K | 17.0% |
| 4 | $25.85 | 6,704 | $173K | 17.0% |
| 5 | $26.74 | 9,370 | $251K | 24.6% |
| 6 | $26.74 | 9,370 |
| $251K |
| 24.6% |
| 7 | $27.39 | 1,134 | $31K | 3.1% |
| Total | $26.16 avg | 38,866 | $1.0M | 100% |
| Filing → |
| RVMD | BUY | 2022-07-25 | $1.0M | — | Filing → |
| COWN | BUY | 2022-02-28 | $901K | — | Filing → |
| MRNA | SELL | 2020-06-04 | $14.1M | — | Filing → |